Generic & Specialty Pharmaceuticals

JERUSALEM (Reuters) - Israel on Wednesday broadened eligibility for a fourth dose of COVID-19 vaccine to include adults under 60...

JAKARTA (Reuters) - Indonesia has approved Merck & Co Inc's COVID-19 antiviral pill molnupiravir for emergency use, the country's food...

By Pushkala Aripaka and Ludwig Burger (Reuters) -AstraZeneca said on Thursday that preliminary data from a trial showed that its...

JAKARTA (Reuters) - Indonesia kicked off its COVID-19 booster programme for the general public on Wednesday, as the world's fourth-most-populous...

By Krishna N. Das NEW DELHI (Reuters) -More than 1 million Indians received their third COVID-19 vaccine dose on Monday...

By Mike Scarcella (Reuters) - A U.S. appeals court on Tuesday revived a lawsuit against AstraZeneca Plc, Pfizer Inc and...

BENGALURU (Reuters) - Serum Institute Of India has applied to the country's drug regulator and the health ministry for full...

BENGALURU (Reuters) - India has approved Merck's COVID-19 pill and two more vaccines for emergency use as the world's second...

ZURICH (Reuters) - Austria should offer some healthcare staff and other key workers a fourth COVID-19 jab, the National Vaccination...

JOHANNESBURG (Reuters) - South Africa will start offering booster shots of Johnson & Johnson's (J&J) COVID-19 vaccine from Friday, the...

By Pushkala Aripaka (Reuters) - A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant,...

(Reuters) - Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron...

MANILA (Reuters) - The Philippines on Thursday approved emergency use of Merck & Co Inc's COVID-19 treatment pill for adult...

By Nancy Lapid (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that...

COPENHAGEN (Reuters) - Getting a third dose of either Pfizer-BioNTech's or Moderna's COVID-19 vaccine offers a "significant increase" in protection...

(Reuters) - Merck & Co Inc has signed deals to sell about 9 million courses of its experimental COVID-19 pill...

By Francesco Guarascio and Pushkala Aripaka (Reuters) - The Serum Institute of India (SII) has waived its protection from legal...

(Reuters) - Pfizer Inc said on Wednesday it will provide an additional 2.5 million doses of its COVID-19 pill Paxlovid...

By Tetsushi Kajimoto and Kiyoshi Takenaka TOKYO (Reuters) -Japanese Prime Minister Fumio Kishida on Tuesday called on shareholders to recognise...

By Deena Beasley (Reuters) - A growing number of countries are reducing the wait time for COVID-19 vaccine boosters from...